Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 Mar;93(3):253–258. doi: 10.1111/j.1349-7006.2002.tb02166.x

Gene Expression for Suppressors of Telomerase Activity (Telomeric‐repeat Binding Factors) in Breast Cancer

Kaori Saito 1, Atsuhito Yagihashi 2, Shunichi Nasu 1, Yoko Izawa 1, Masashi Nakamura 2, Daisuke Kobayashi 2, Naoki Tsuji 2, Naoki Watanabe 2,✉
PMCID: PMC5926971  PMID: 11927006

Abstract

Mechanisms regulating telomerase activity and telomere length remain incompletely understood in human breast cancer. We therefore studied gene expression for telomeric‐repeat binding factors (TRFs) in relation to telomerase activity, telomere length, and clinicopathologic factors in human breast cancer. Telomerase activity was detected in 65.8% of 38 breast cancers, but none of 16 non‐cancerous samples. Terminal restriction fragments were longer in noncancerous than in cancerous tissues, but not significantly. Among 8 patients with both cancer and paired noncancerous tissue available for terminal restriction fragments length assay, terminal restriction fragments were shorter in cancers than in paired noncancerous samples in all but one. Significantly more mRNA encoding TRF1 and 2 was detected in noncancerous than in cancer tissues. Additionally, expression of TRF1 and 2 mRNA was significantly higher in cancers without detectable telomerase activity than in cancers showing activity. Expression of these genes tended to show a negative correlation with terminal restriction fragments length, but this was not statistically significant. No correlation was seen between TRF1 or 2 mRNA expression, and clinicopathologic factors except for TRF1 with respect to tumor size and progesterone receptor status. In addition to reactivation of telomerase activity, escape from negative regulation of this activity is needed to maintain telomere length during cell proliferation in breast cancer. Genes encoding telomerase inhibitors might be of value in gene therapy against human breast cancer.

Keywords: Telomeric‐repeat binding factors, Breast cancer, Telomere length, Telomerase activity, Gene expression

Full Text

The Full Text of this article is available as a PDF (88.8 KB).

REFERENCES

  • 1.Slamon , D. J. , Clark , G. M. , Wong , S. G. , Levin , W. J. , Ullrich , A. and McGuire , W. L.Human breast cancer: correlation of relapse and suvival with amplification of the HER2/neu oncogene . Science , 235 , 177 – 182 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 2.Houston , S. J. , Plunkett , T. A. , Barnes , D. M. , Smith , P. , Rubens , R. D. and Miles , D. W.Overexoression of c‐eabB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer . Br. J. Cancer , 79 , 1220 – 1226 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Turner , B. C. , Gumbs , A. A. , Carbone , C. J. , Carter , D. , Glazer , P. M. and Haffty , B. G.Mutant p53protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy . Cancer , 88 , 1091 – 1098 ( 2000. ). [PubMed] [Google Scholar]
  • 4.Lee , W. Y. , Jin , Y. T. , Chang , T. W. , Lin , P. W. and Su , I. J.Immunocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal cartinomas: a correlation with other biological parameters . Histopathology , 34 , 106 – 112 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 5.Hilakivi‐Clarke , L.Estrogens, BRCA1, and breast cancer . Cancer Res. , 60 , 4993 – 5001 ( 2000. ). [PubMed] [Google Scholar]
  • 6.Osrio , A. , Barroso , A. , Martinez , B. , Cebrian , A. , San Roman , J. M. , Lobo , F. , Robledo , M. and Benitez , J.Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families . Br. J. Cancer , 82 , 1266 – 1270 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Greader , C. W. and Blackburn , E. H.Identification of a specific telomere terminal transferase activity in tetrahymena extracts . Cell , 43 , 405 – 413 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 8.Kim , N. W. , Piatyszek , M. A. , Prowse , K. R. , Harley , C. B. , West , M. D. , Ho , P. L. , Coviello , G. M. , Wright , W. E. , Weinrich , S. L. and Shay , J. W.Specific assosiation of human telomerase activity wit immortal cells and cancer . Science , 266 , 2011 – 2015 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 9.Shay , J. and Bacchetti , S.A survey of telomerase activity in human cancer . Eur. J. Cancer , 33 , 787 – 791 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 10.Hiyama , E. , Yokoyama , T. , Tatsumoto , N. , Hiyama , K. , Imamura , Y. , Murakami , Y. , Kodama , T. , Piatyszek , M. A. , Shay , J. W. and Matsuura Y.Telomerase activity in gastric cancer . Cancer Res. , 55 , 3258 – 3262 ( 1995. ). [PubMed] [Google Scholar]
  • 11.Lin , Y. , Miyamoto , H. , Fujinami , K. , Uemura , H. , Hosaka , M. , Iwasaki , Y. and Kubota , Y.Telomerase activity in bladder cancer . Clin. Cancer Res. , 2 , 929 – 932 ( 1996. ). [PubMed] [Google Scholar]
  • 12.Chadeneau , C. , Hay , K. , Hirte , H. W. , Gallinger , S. and Bacchetti , S.Telomerase activity associated with acquisition of malignancy in human colorectal cancer . Cancer Res. , 55 , 2533 – 2563 ( 1995. ). [PubMed] [Google Scholar]
  • 13.Sommerfeld , H. J. , Meeker , A. K. , Piatyszek , M. A. , Bova , G. S. , Shay , J. W. and Coffey , D. S.Telomerase activity: a prevalent marker of malignant human prostate tissue . Cancer Res. , 56 , 218 – 222 ( 1996. ). [PubMed] [Google Scholar]
  • 14.Kojima , H. , Yokosuka , O. , Imazeki , F. , Saisho , H. and Omata , M.Telomarase activity and telomere length in hepatocellular carcinoma and chronic liver disease . Gastroenterology , 112 , 493 – 500 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 15.Chong , L. , Van Steensel , B. , Broccoli , D. , Erdjument‐Bromage , H. , Hanish , J. , Tempst , P. and de Lange , T.A human telomeric protein . Science , 270 , 1663 – 1667 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 16.Steensel , B. and Lange , D.Control of telomere length by the human telomeric protein TRF1 . Nature , 385 , 740 – 743 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 17.Steensel , B. , Smogorzewska , A. and Lange , D.TRF2 protects human telomeres from end‐to‐end fusions . Cell , 92 , 401 – 413 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 18.Broccoli , D. , Smogorzewska , A. , Chong , L. and Lange , D.Human telomeres contain two distinct Myb‐related proteins, TRF1 and TRF2 . Nat. Genet. , 17 , 231 – 235 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 19.Griffith , J. D. , Comeau , L. , Rosenfield , S. , Stansel , R. M. , Bianchi , A. , Moss , H. and de Lange , T.Mammalian telomeres end in a large duplex loop . Cell , 97 , 503 – 514 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 20.The Japanese Breast Cancer Society . “ General Rules for Clinical and Pathological Recording of Breast Cancer ,” 12th Ed. ( 1996. ). Kanehara Co. , Tokyo . [Google Scholar]
  • 21.Kim , N. W. and Wu , F.Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) . Nucleic Acids Res. , 25 , 2595 – 2597 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yajima , T. , Yagihashi , A. , Kameshima , H. , Furuya , D. , Kobayashi , D. , Hirata , K. and Watanabe , N.Establishment of quantitative reverse transcription‐polymerase chain reaction assays for human telomerase‐associated genes . Clin. Chim. Acta , 290 , 117 – 127 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 23.Yajima , T. , Yagihashi , A. , Kameshima , H. , Kobayashi , D. , Furuya , D. , Hirata , K. and Watanabe , N.Quantitative reverse transcription‐PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system . Clin. Chem. , 44 , 2441 – 2445 ( 1998. ). [PubMed] [Google Scholar]
  • 24.Yamada , K. , Yajima , T. , Yagihashi , A. , Kobayashi , D. , Koyanagi , Y. , Asanuma , K. , Yamada , M. , Moriai , R. , Kameshima , H. and Watanabe , N.Role of human telomerase reverse transcriptase and telomeric‐repeat binding factor proteins 1 and 2 in human hematopoietic cells . Jpn. J. Cancer Res. , 91 , 1278 – 1284 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rha , S. Y. , Park , K. H. , Kim , T. S. , Yoo , N. C. , Yang , W. L , Roh , J. K. , Min , J. S. , Lee , K. S. , Kim , B. S. , Choi , J. H. , Lim , H. Y. and Chung , H. C.Changes of telomerase and telomere length in paired normal and cancer tissues of breast . Int. J. Oncol , 15 , 839 – 845 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 26.Mokbel , K. , Parris , C. N. , Radbourne , R. , Ghilchik , M. and Newbold , R. F.Telomerase activity and prognosis in breast cancer . Eur. J. Surg. Oncol , 25 , 269 – 272 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 27.Carey , L. A. , Kim , N. W. , Goodman , S. , Marks , J. , Henderson , G. , Umbricht , C. B. , Dome , J. S. , Dooley , W. , Amshey , S. R. and Sukumar , S.Telomerase activity and prognosis in primary breast cancers . J. Clin. Oncol. , 17 , 3075 – 3081 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 28.Piere , R. , Corina , R. , Ullrich , B. and Jorn , B.Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancer . Cancer Lett. , 106 , 155 – 161 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 29.Dunham , M. A. , Neumann , A. A. , Fasching , C. L. and Reddel , R. R.Telomere maintenance by recombination in human cells . Nat. Genet , 26 , 388 – 389 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 30.Cohen , H. and Sinclair , D. A.Recombination‐mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase . Proc. Nad. Acad. Sci. USA , 98 , 3174 – 3179 ( 2001. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES